Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid Syndrome

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inClinical and Diagnostic Laboratory Immunology Vol. 7; no. 2; pp. 241 - 244
Main Authors Ordi-Ros, Josep, Villarreal, Julieta, Monegal, Francesc, Sauleda, Silvia, Esteban, Ignacio, Vilardell, Miquel
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.03.2000
Subjects
Adolescent
Adult
Aged
Antibodies, Anticardiolipin - blood
Antibodies, Anticardiolipin - immunology
anticardiolipin antibodies
antiphospholipid syndrome
Antiphospholipid Syndrome - immunology
Cross Reactions
Female
Hepatitis C virus
Hepatitis C, Chronic - blood
Hepatitis C, Chronic - immunology
Humans
Immune-Mediated Responses and Disorders
Lupus Coagulation Inhibitor - blood
Male
Middle Aged
Parietal Cells, Gastric - immunology
Online AccessGet full text
ISSN1556-6811
1071-412X
1556-679X
1098-6588
DOI10.1128/CDLI.7.2.241-244.2000

Cover

Abstract Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       
AbstractList The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent fetal losses, and thrombocytopenia, along with the presence of anticardiolipin (aCL) antibodies and/or lupus anticoagulant. Various infectious diseases can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with autoimmune diseases, in which these antibodies need the presence of beta(2)-glycoprotein I. Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with chronic hepatitis C virus (HCV) infection and 100 healthy controls. Clinical events of APS, the level of beta(2)-glycoprotein dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated. Positive results for aCL antibodies were found more frequently (3. 3%) for the patients with HCV infection than for healthy controls (0%). All positive aCL antibodies were beta(2)-glycoprotein I independent. No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL. Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed. As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients.
The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent fetal losses, and thrombocytopenia, along with the presence of anticardiolipin (aCL) antibodies and/or lupus anticoagulant. Various infectious diseases can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with autoimmune diseases, in which these antibodies need the presence of β 2 -glycoprotein I. Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with chronic hepatitis C virus (HCV) infection and 100 healthy controls. Clinical events of APS, the level of β 2 -glycoprotein dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated. Positive results for aCL antibodies were found more frequently (3.3%) for the patients with HCV infection than for healthy controls (0%). All positive aCL antibodies were β 2 -glycoprotein I independent. No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL. Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed. As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients.
The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent fetal losses, and thrombocytopenia, along with the presence of anticardiolipin (aCL) antibodies and/or lupus anticoagulant. Various infectious diseases can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with autoimmune diseases, in which these antibodies need the presence of beta(2)-glycoprotein I. Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with chronic hepatitis C virus (HCV) infection and 100 healthy controls. Clinical events of APS, the level of beta(2)-glycoprotein dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated. Positive results for aCL antibodies were found more frequently (3. 3%) for the patients with HCV infection than for healthy controls (0%). All positive aCL antibodies were beta(2)-glycoprotein I independent. No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL. Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed. As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients.The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent fetal losses, and thrombocytopenia, along with the presence of anticardiolipin (aCL) antibodies and/or lupus anticoagulant. Various infectious diseases can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with autoimmune diseases, in which these antibodies need the presence of beta(2)-glycoprotein I. Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with chronic hepatitis C virus (HCV) infection and 100 healthy controls. Clinical events of APS, the level of beta(2)-glycoprotein dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated. Positive results for aCL antibodies were found more frequently (3. 3%) for the patients with HCV infection than for healthy controls (0%). All positive aCL antibodies were beta(2)-glycoprotein I independent. No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL. Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed. As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients.
Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI       
The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent fetal losses, and thrombocytopenia, along with the presence of anticardiolipin (aCL) antibodies and/or lupus anticoagulant. Various infectious diseases can induce aCL; however, these antibodies are not usually associated with thrombotic events, as happens with autoimmune diseases, in which these antibodies need the presence of beta sub(2)-glycoprotein I. Levels of immunoglobulin G (IgG) and IgM aCL antibodies were determined by enzyme-linked immunosorbent assay for 243 patients with chronic hepatitis C virus (HCV) infection and 100 healthy controls. Clinical events of APS, the level of beta sub(2)-glycoprotein dependence of aCL, the presence of cryoglobulins and other autoantibodies, and cross-reactivity between purified aCL and HCV were evaluated. Positive results for aCL antibodies were found more frequently (3.3%) for the patients with HCV infection than for healthy controls (0%). All positive aCL antibodies were beta sub(2)-glycoprotein I independent. No significant association was found between aCL antibodies and clinical manifestations of APS, neither was one found between the presence of other autoantibodies or cryoglobulins and that of aCL. Finally, no cross-reactivity between aCL antibodies and HCV antigens was observed. As previously reported, aCL antibodies seem to be an epiphenomenon, and they do not have clinical or laboratory significance in HCV patients.
Author Josep Ordi-Ros
Miquel Vilardell
Ignacio Esteban
Francesc Monegal
Julieta Villarreal
Silvia Sauleda
AuthorAffiliation Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
AuthorAffiliation_xml – name: Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
Author_xml – sequence: 1
  givenname: Josep
  surname: Ordi-Ros
  fullname: Ordi-Ros, Josep
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
– sequence: 2
  givenname: Julieta
  surname: Villarreal
  fullname: Villarreal, Julieta
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
– sequence: 3
  givenname: Francesc
  surname: Monegal
  fullname: Monegal, Francesc
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
– sequence: 4
  givenname: Silvia
  surname: Sauleda
  fullname: Sauleda, Silvia
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
– sequence: 5
  givenname: Ignacio
  surname: Esteban
  fullname: Esteban, Ignacio
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
– sequence: 6
  givenname: Miquel
  surname: Vilardell
  fullname: Vilardell, Miquel
  organization: <!--label omitted: 1-->Department of Internal Medicine, Vall d'Hebron Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/10702499$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu1DAUtVAr-oBPAHnFLqntOHECbKrw6EgjgXiJneU4TnNRYk9tD1X5BL4ap9PhtYDFlX2vz7n32D4n6MA6axB6RElOKavP2hfrVS5yljNOM8Z5zggh99AxLcsqq0Tz-WC_ryk9QichfCGEF1Ut7qMjSgRhvGmO0fdzG0Er34ObYAMWL3nnejABp-ytimBsDPga4ojb0TsLGl-YTapHCLjFn8BvA17ZwegIzj5NIOWVjsbDN7VUljbvzLTbR3c7YDO6kGKZ2OP3N7b3bjYP0OGgpmAe3q2n6OOrlx_ai2z95vWqPV9nmlc0ZkJ0BS26gtO-4qKrOjUIsRQUaZjohp5zWrKKdqxiA1O6MoQSNiiiG0P7ui5O0fNd3822m02v0_28muTGw6z8jXQK5J8nFkZ56b7KpqzLMtGf3NG9u9qaEOUMQZtpUta4bZCCNGVZk-a_QCp4zQVbBD3-XdBPJftfSoBnO4D2LgRvBqkh3j5o0gdTAsrFE3LxhBSSyeSJFFwunkjs8i_2rwH_5uEdb4TL8Rq8kSrMUvcT7LHFD4Deyao
CitedBy_id crossref_primary_10_1136_ard_2003_014175
crossref_primary_10_1177_0961203318809177
crossref_primary_10_1016_j_hoc_2007_10_001
crossref_primary_10_1016_S0025_7753_01_71958_6
crossref_primary_10_1046_j_1365_2362_2003_01110_x
crossref_primary_10_1016_j_radcr_2024_06_078
crossref_primary_10_1016_j_autrev_2011_11_011
crossref_primary_10_3390_ijms18061304
crossref_primary_10_1016_j_amjmed_2003_08_034
crossref_primary_10_1007_s10238_024_01400_5
crossref_primary_10_1007_s10067_005_0032_1
crossref_primary_10_1016_j_autrev_2007_10_001
crossref_primary_10_1016_j_ajg_2021_12_003
crossref_primary_10_1016_j_dld_2007_11_029
crossref_primary_10_5045_kjh_2011_46_1_36
crossref_primary_10_1016_j_revmed_2008_05_020
crossref_primary_10_1016_S0014_2565_02_71033_3
crossref_primary_10_1136_ard_60_5_500
crossref_primary_10_1067_mlc_2002_128467
crossref_primary_10_1097_00002281_200109000_00013
crossref_primary_10_1053_sarh_2002_28303
crossref_primary_10_1111_j_1365_2249_2005_02727_x
crossref_primary_10_1177_1076029610369797
crossref_primary_10_1177_0961203317731532
crossref_primary_10_1097_MD_0000000000001296
crossref_primary_10_1016_S0168_8278_01_00024_1
crossref_primary_10_3748_wjg_v22_i18_4427
crossref_primary_10_1097_00003246_200204000_00007
crossref_primary_10_1111_j_1365_2893_2010_01366_x
crossref_primary_10_1136_ard_62_5_388
crossref_primary_10_1186_ar2091
crossref_primary_10_1111_j_1365_2249_2005_02923_x
crossref_primary_10_1093_ndt_gfk017
crossref_primary_10_1002_jcla_21529
crossref_primary_10_1097_00041552_200103000_00004
crossref_primary_10_1902_jop_2007_060305
crossref_primary_10_5144_0256_4947_2003_127
crossref_primary_10_1016_j_dld_2015_03_006
crossref_primary_10_1191_0961203303lu340oa
crossref_primary_10_1016_j_imbio_2005_10_003
crossref_primary_10_1097_01_meg_0000059144_68845_61
crossref_primary_10_1097_MD_0000000000000496
crossref_primary_10_1177_0961203315595129
crossref_primary_10_3389_fimmu_2023_1129201
crossref_primary_10_1259_bjr_21010811
crossref_primary_10_1007_s11926_021_01038_2
crossref_primary_10_1016_j_autrev_2008_05_004
crossref_primary_10_1093_rheumatology_ken303
crossref_primary_10_1016_S0035_3787_06_75128_1
crossref_primary_10_1016_j_cellimm_2011_08_002
crossref_primary_10_1007_s11926_001_0031_4
crossref_primary_10_1016_j_jhep_2009_06_023
crossref_primary_10_1080_24725625_2017_1320464
crossref_primary_10_1007_s12016_008_8103_0
crossref_primary_10_1016_S0025_7753_02_73579_3
crossref_primary_10_1007_s11926_007_0034_x
Cites_doi 10.1016/S0168-8278(05)80281-8
10.1016/S0022-2143(98)90096-8
10.1093/ajcp/94.4.476
10.1038/227680a0
10.1016/0140-6736(90)91697-9
10.1001/jama.1988.03720040042024
10.1177/096120339200100204
10.1093/clinids/24.2.197
10.1073/pnas.87.11.4120
10.1055/s-0037-1614978
10.1016/S0049-0172(97)80041-8
10.1111/j.1365-2141.1978.tb03648.x
10.1055/s-0038-1653795
10.1016/S0140-6736(83)91267-9
10.1046/j.1365-2141.1998.00722.x
10.1093/clinids/18.2.213
10.1002/art.1780400115
10.1016/0049-3848(88)90136-3
10.1002/art.1780390903
10.1002/hep.510230201
10.1182/blood.V68.4.869.869
ContentType Journal Article
Copyright Copyright © 2000, American Society for Microbiology 2000
Copyright_xml – notice: Copyright © 2000, American Society for Microbiology 2000
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7U9
H94
7X8
5PM
DOI 10.1128/CDLI.7.2.241-244.2000
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
MEDLINE - Academic

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1556-679X
1098-6588
EndPage 244
ExternalDocumentID PMC95855
10702499
10_1128_CDLI_7_2_241_244_2000
cdli_7_2_241
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID .GJ
18M
29B
2WC
53G
5GY
6J9
AAFWJ
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
EBS
F5P
GX1
HYE
RHI
RPM
RSF
TR2
W2D
W8F
WOQ
CGR
CUY
CVF
ECM
EIF
NPM
RHF
7T5
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-c461t-77b313b341d647b6baf7713b3a0927bfd4415261b262f2ac6e0102fa0c9e1d883
ISSN 1556-6811
1071-412X
IngestDate Thu Aug 21 17:47:51 EDT 2025
Thu Jul 10 22:38:16 EDT 2025
Fri Jul 11 12:13:57 EDT 2025
Sat Sep 28 08:40:41 EDT 2024
Tue Jul 01 00:54:49 EDT 2025
Thu Apr 24 23:09:28 EDT 2025
Wed May 18 15:27:12 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c461t-77b313b341d647b6baf7713b3a0927bfd4415261b262f2ac6e0102fa0c9e1d883
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Mailing address: Josep Ordi-Ros, C/Nord 49 casa 34, 08950 Esplugues de Llobregat, Barcelona, Spain. Phone: 34-93-489 40 47. Fax: 34-93-489 40 45. E-mail: ordiros@hg.vhebron.es.
OpenAccessLink https://doi.org/10.1128/cdli.7.2.241-244.2000
PMID 10702499
PQID 17484728
PQPubID 23462
PageCount 4
ParticipantIDs proquest_miscellaneous_17484728
crossref_primary_10_1128_CDLI_7_2_241_244_2000
highwire_asm_cdli_7_2_241
proquest_miscellaneous_70955809
crossref_citationtrail_10_1128_CDLI_7_2_241_244_2000
pubmedcentral_primary_oai_pubmedcentral_nih_gov_95855
pubmed_primary_10702499
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20000301
2000-03-00
2000-Mar
PublicationDateYYYYMMDD 2000-03-01
PublicationDate_xml – month: 03
  year: 2000
  text: 20000301
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical and Diagnostic Laboratory Immunology
PublicationTitleAlternate Clin Diagn Lab Immunol
PublicationYear 2000
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
De Larrañaga G. (e_1_3_2_9_2) 1996; 5
e_1_3_2_28_2
Matsuda J. (e_1_3_2_21_2) 1995; 90
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
Ordi J. (e_1_3_2_25_2) 1993; 20
Brandt J. T. (e_1_3_2_5_2) 1995; 74
Harris E. N. (e_1_3_2_13_2) 1987; 68
Harris E. N. (e_1_3_2_12_2) 1987; 26
e_1_3_2_15_2
e_1_3_2_16_2
e_1_3_2_17_2
e_1_3_2_18_2
e_1_3_2_19_2
Garcia-Bragado F. (e_1_3_2_11_2) 1986; 45
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_4_2
e_1_3_2_33_2
e_1_3_2_2_2
e_1_3_2_14_2
Alarcon-Segovia D. (e_1_3_2_3_2) 1989; 16
Clifford B. D. (e_1_3_2_7_2) 1995; 21
Cacoub P. (e_1_3_2_6_2) 1997; 24
Cowchock S. (e_1_3_2_8_2) 1988; 73
References_xml – ident: e_1_3_2_2_2
  doi: 10.1016/S0168-8278(05)80281-8
– ident: e_1_3_2_4_2
  doi: 10.1016/S0022-2143(98)90096-8
– ident: e_1_3_2_14_2
  doi: 10.1093/ajcp/94.4.476
– ident: e_1_3_2_18_2
  doi: 10.1038/227680a0
– volume: 5
  start-page: 521
  year: 1996
  ident: e_1_3_2_9_2
  article-title: Low prevalence of autoimmune antiphospholipid antibodies in infectious diseases of the liver.
  publication-title: Lupus
– volume: 90
  start-page: 1138
  year: 1995
  ident: e_1_3_2_21_2
  article-title: High prevalence of aPL antibodies and anti-thyroglobulin antibodies in patients with hepatitis C virus infection treated with interferon-α.
  publication-title: Am. J. Gastroenterol.
– volume: 73
  start-page: 289
  year: 1988
  ident: e_1_3_2_8_2
  article-title: False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion.
  publication-title: Clin. Exp. Immunol.
– ident: e_1_3_2_22_2
  doi: 10.1016/0140-6736(90)91697-9
– ident: e_1_3_2_33_2
  doi: 10.1001/jama.1988.03720040042024
– volume: 68
  start-page: 215
  year: 1987
  ident: e_1_3_2_13_2
  article-title: Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986.
  publication-title: Clin. Exp. Immunol.
– ident: e_1_3_2_16_2
  doi: 10.1177/096120339200100204
– ident: e_1_3_2_17_2
  doi: 10.1093/clinids/24.2.197
– ident: e_1_3_2_24_2
  doi: 10.1073/pnas.87.11.4120
– ident: e_1_3_2_31_2
  doi: 10.1055/s-0037-1614978
– volume: 24
  start-page: 2139
  year: 1997
  ident: e_1_3_2_6_2
  article-title: Anticardiolipin, anti-β2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia.
  publication-title: J. Rheumatol.
– ident: e_1_3_2_30_2
  doi: 10.1016/S0049-0172(97)80041-8
– ident: e_1_3_2_10_2
  doi: 10.1111/j.1365-2141.1978.tb03648.x
– volume: 26
  start-page: 19
  year: 1987
  ident: e_1_3_2_12_2
  article-title: Clinical and serological features of the antiphospholipid syndrome.
  publication-title: Br. J. Rheumatol.
– ident: e_1_3_2_28_2
  doi: 10.1055/s-0038-1653795
– ident: e_1_3_2_15_2
  doi: 10.1016/S0140-6736(83)91267-9
– volume: 16
  start-page: 482
  year: 1989
  ident: e_1_3_2_3_2
  article-title: Primary antiphospholipid syndrome.
  publication-title: J. Rheumatol.
– ident: e_1_3_2_19_2
  doi: 10.1046/j.1365-2141.1998.00722.x
– volume: 74
  start-page: 1185
  year: 1995
  ident: e_1_3_2_5_2
  article-title: Criteria for the diagnosis of the lupus anticoagulants: an update.
  publication-title: Thromb. Haemostasis
– ident: e_1_3_2_26_2
  doi: 10.1093/clinids/18.2.213
– ident: e_1_3_2_20_2
  doi: 10.1002/art.1780400115
– volume: 45
  start-page: 159
  year: 1986
  ident: e_1_3_2_11_2
  article-title: Lymphocyte subpopulations in essential mixed cryoglobulinemia.
  publication-title: Ann. Rheum. Dis.
– volume: 20
  start-page: 1321
  year: 1993
  ident: e_1_3_2_25_2
  article-title: Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis.
  publication-title: J. Rheumatol.
– ident: e_1_3_2_23_2
  doi: 10.1016/0049-3848(88)90136-3
– ident: e_1_3_2_29_2
  doi: 10.1002/art.1780390903
– ident: e_1_3_2_27_2
  doi: 10.1002/hep.510230201
– ident: e_1_3_2_32_2
  doi: 10.1182/blood.V68.4.869.869
– volume: 21
  start-page: 613
  year: 1995
  ident: e_1_3_2_7_2
  article-title: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
  publication-title: Hepatology
SSID ssj0043687
ssj0014330
Score 1.8653256
Snippet Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
The antiphospholipid syndrome (APS) is usually defined by the association of clinical manifestations that comprise venous and/or arterial thrombosis, recurrent...
SourceID pubmedcentral
proquest
pubmed
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 241
SubjectTerms Adolescent
Adult
Aged
Antibodies, Anticardiolipin - blood
Antibodies, Anticardiolipin - immunology
anticardiolipin antibodies
antiphospholipid syndrome
Antiphospholipid Syndrome - immunology
Cross Reactions
Female
Hepatitis C virus
Hepatitis C, Chronic - blood
Hepatitis C, Chronic - immunology
Humans
Immune-Mediated Responses and Disorders
Lupus Coagulation Inhibitor - blood
Male
Middle Aged
Parietal Cells, Gastric - immunology
Title Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid Syndrome
URI http://cvi.asm.org/content/7/2/241.abstract
https://www.ncbi.nlm.nih.gov/pubmed/10702499
https://www.proquest.com/docview/17484728
https://www.proquest.com/docview/70955809
https://pubmed.ncbi.nlm.nih.gov/PMC95855
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFDbrEIgXBOMWLsMPvE0pjePGCW9TAI3LYMA27S1yEodFytqqSZHgJ_CrOcd20rQUAXtI1Dp2nPR8tY_t73wm5FmWKV-EhXSDUDGXBzJww8KPNHFN5hEHFGm2xYfg4IS_PRufbQ2u9FhLiyYdZj82xpVcxqqQBnbFKNn_sGx3U0iAz2BfOIOF4fxPNt6f4Ew0Ekor3IIalQDKdIq8QJzGODKSqTZ-zargQj-DHOqmrPfivdNyvqihiTB8LM3xiDsBZxOfiTdqCXPop2IVs_NpDQfWCd7qJsmDNtwSZ-VzQ-ZDYViLOFzWLzEuZWVK_yO8h_t5ulyXaC-c4sZIc3BuqzagWzVdZwJtkvpqrug9QlSddZNGclGpXDvHX8rqWylXZjhGS4pXL6gAW7sej_WwXOpU9ZpvcJhc7ukN2qF3s2lR6IKfFfbbfNGDNuu330aFy7oCzEhT_t7LMIyciF--fzMUQzaEQi5k1VFP_fxgtdmFhh48F0ozRstOt6NCHh3GEQzZxgNylQmhmQZ6wskuhHHfN4Ia9sVsEBo8wfON9aMIrq1s1dNq1a83jaTWCcE9D-v4Frlph0Z03-D8NtlSkx1yzWyW-n2HXD-0NJA75Oca8OkS-BS-tcCnCHxqgU874NOYauDTDvgv6Drs8TYt7Gkzpeuwpy3s75KT16-O4wPXbiriZjzwGhhNpr7np-C85QEXaZDKAn52SJCjiIm0yHGCgQVeygJWMJkFClUXCznKIuXlYejfI9sTgPYDQpGAnXOhWJoLznMZgW_nR7JIeQRuci4cwlsDJJlV3MeNX6pEj7xZmKAJE5GwBEwIB8dNYUcOGXbFZkZy5m8FnNa6iawvkiyvyjaTQ5625k6g48DVQDlR00WdeKgiLFj45xwC5SnDUeSQ-wYevccxEHPIeAU4XQYUrV-9MinPtXi9BvvDS5Z7RG4sG4jHZLuZL9QTGBQ06S4ZvPsU7uo_zy8eXRQ1
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anticardiolipin+Antibodies+in+Patients+with+Chronic+Hepatitis+C+Virus+Infection%3A+Characterization+in+Relation+to+Antiphospholipid+Syndrome&rft.jtitle=Clinical+and+diagnostic+laboratory+immunology&rft.au=Ordi-Ros%2C+Josep&rft.au=Villarreal%2C+Julieta&rft.au=Monegal%2C+Francesc&rft.au=Sauleda%2C+Silvia&rft.date=2000-03-01&rft.pub=American+Society+for+Microbiology&rft.issn=1071-412X&rft.eissn=1098-6588&rft.volume=7&rft.issue=2&rft.spage=241&rft.epage=244&rft_id=info:doi/10.1128%2FCDLI.7.2.241-244.2000&rft_id=info%3Apmid%2F10702499&rft.externalDocID=PMC95855
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-6811&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-6811&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-6811&client=summon